Johannes van Den Anker
Neonatal-Perinatal Medicine · Washington, DCNPI 1598842957
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $148,880 of the $165,519 with a category attached, or 89.9%. 16 manufacturers reported payments, led by Shionogi Inc at 28.7% of the total. Among neonatal-perinatal medicine clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $1546.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shionogi Inc$47K
- Eli Lilly$30K
- Daiichi Sankyo Inc.$25K
- Pfizer$12K
- Viiv Healthcare Company$8K
- Janssen Research & Development, LLC$8K
- plus $36K from 10 others
Across 3 payments — averaging $2383.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$3K
- Roche Products Limited$2K
- Endo Pharmaceuticals Inc.$2K
What the payments were for
- Consulting fees$148,88090%
- Speaking & faculty fees$3,6402%
- Travel & lodging$12,2937%
- Food & beverage$7050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shionogi Inc | 30 | $47,440 |
| Eli Lilly | 11 | $29,525 |
| Daiichi Sankyo Inc. | 21 | $24,948 |
| Pfizer | 7 | $11,532 |
| Viiv Healthcare Company | 2 | $8,000 |
| Janssen Research & Development, LLC | 4 | $7,600 |
| American Regent | 3 | $7,495 |
| UCB SA | 4 | $6,560 |
| Vertex | 14 | $4,581 |
| Intercept Pharmaceuticals, Inc. | 1 | $3,640 |
| Trevena, Inc. | 1 | $3,200 |
| Roche Products Limited | 2 | $3,120 |
| F. Hoffmann-la Roche AG | 2 | $2,730 |
| Endo Pharmaceuticals Inc. | 3 | $2,440 |
| Hexal AG | 1 | $2,298 |
| UCB GmbH | 1 | $410 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$165,519 in reported general payments places this provider in the 95th percentile of 41 neonatal-perinatal medicine providers in District of Columbia.
See all neonatal-perinatal medicine providers in District of Columbia →
Other neonatal-perinatal medicine in Washington
- Billie Lou ShortWashington$5K
- Khodayar Rais-BahramiWashington$4K
- Ha-Young ChoiWashington$463
- James MorrisWashington$250
- Sudeepta BasuWashington$201
- Jennifer PakWashington$198
- Sheila Owens-CollinsWashington$168
- Deborah HoyWashington$138
- Richelle ReinhartWashington$128
- Zoya CheemaWashington$127
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.